Key Findings:  The authors posit that while cannabis may improve symptom management (e.g. abdominal pain, joint pain, abdominal cramping, and diarrhea), it has not been proven to help with inflammation or to fundamentally correct underlying pathologies of IBD. In addition, the authors are concerned about the potential adverse effects of cannabinoid-based therapeutics.
Type of Study:  Meta-analysis
Study Result:  Inconclusive
Research Location(s):  United States
Year of Pub:  2021
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified
Citation:  Buckley MC, et al. Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians. Adv Ther. 2021; 38:4152-4161. doi: 10.1007/s12325-021-01805-8
Authors:  Buckley MC, Kumar A, Swaminath A